Mallinckrodt Pharmaceuticals has recalled one batch of its sodium chromate Cr-51 diagnostic agent after FDA post-marketing tests revealed that some of the products were “subpotent.”
Orphan drug Soliris (eculizumab) has been approved by the European
Commission and marks the first therapy for a rare and
life-threatening blood disease.
US biotech company Alexion has been given the green light by
European regulators to market its new orphan drug Soliris
(eculizumab) - the first therapy to be approved under the EU's new
fast-track review process.
Croatian pharmaceutical company Pliva has won its first European
approval for generic erythropoietin, a biologic drug used for the
treatment of low red blood cell counts, reports Phil Taylor.
Researchers in the US have developed a way to make large,
protein-based drugs suitable for oral rather than injectable
delivery by fusing them with a carrier molecule, reports Phil
Taylor.
Croatian pharmaceutical company Pliva has forged another
partnership in the generic biopharmaceutical sector, linking up
with US firm Barr Laboratories to develop a generic version of
Amgen's white blood cell stimulator Neupogen...
Croatia's Pliva, the largest pharmaceutical company in Eastern
Europe, has teamed up with Australia's Mayne Pharma to hasten the
development of two 'generic' biologic drugs.
